Cardlytics (CDLX) to Release Quarterly Earnings on Wednesday

Cardlytics (NASDAQ:CDLX - Get Free Report) is set to issue its quarterly earnings data after the market closes on Wednesday, May 8th. Cardlytics has set its Q1 2024 guidance at EPS.Parties that wish to listen to the company's conference call can do so using this link.

Cardlytics (NASDAQ:CDLX - Get Free Report) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) EPS for the quarter. The business had revenue of $89.17 million during the quarter. Cardlytics had a negative net margin of 43.56% and a negative return on equity of 25.38%.

Cardlytics Trading Up 6.0 %

Shares of NASDAQ:CDLX traded up $0.74 during midday trading on Wednesday, reaching $12.99. The company's stock had a trading volume of 743,435 shares, compared to its average volume of 1,484,444. The firm has a market cap of $625.73 million, a price-to-earnings ratio of -3.80 and a beta of 1.44. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 1.91. Cardlytics has a 1 year low of $4.94 and a 1 year high of $20.52. The business has a 50 day moving average price of $11.65 and a 200 day moving average price of $9.61.

Insider Activity at Cardlytics

In related news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of the business's stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $13.69, for a total value of $170,577.40. Following the completion of the sale, the insider now directly owns 71,355 shares of the company's stock, valued at $976,849.95. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of the company's stock in a transaction that occurred on Tuesday, April 2nd. The stock was sold at an average price of $13.69, for a total transaction of $170,577.40. Following the completion of the transaction, the insider now directly owns 71,355 shares of the company's stock, valued at $976,849.95. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Amit Gupta sold 23,416 shares of the company's stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $11.91, for a total value of $278,884.56. Following the transaction, the chief operating officer now directly owns 122,676 shares of the company's stock, valued at $1,461,071.16. The disclosure for this sale can be found here. Insiders sold a total of 36,306 shares of company stock valued at $455,203 over the last three months. 4.40% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

CDLX has been the subject of a number of recent analyst reports. Lake Street Capital lifted their price objective on Cardlytics from $13.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, March 15th. Needham & Company LLC boosted their price target on Cardlytics from $15.00 to $17.00 and gave the company a "buy" rating in a research report on Tuesday, April 9th. Finally, Craig Hallum raised Cardlytics from a "hold" rating to a "buy" rating and boosted their price target for the company from $10.00 to $18.00 in a research report on Friday, March 15th.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.